[Collagen diseases with opportunistic infections]
- PMID: 15291252
- DOI: 10.2177/jsci.27.156
[Collagen diseases with opportunistic infections]
Abstract
Treatment of opportunistic infections emerging in collagen diseases is very important as well as the therapy of original diseases. Lung tuberculosis, Pneumocystis carinii and lung fungal infections are main opportunistic infections. There is effective prophylaxis against them, though the cases for their administration should be carefully chosen because of their adverse effects. We have administrated INH and ST (Sulphomethoxazole and Trimethoprim) more than 15 years as the prophylaxis against tuberculosis and P. carinii to the cases who are treated more than 60 mg of prednisolone per day as an initial dose until less than 30 mg per day and completely succeeded. Infliximab treatment has been reported that it often induces tuberculosis in abroad and lots of occurrence was anticipated in Japan where high incidence of tuberculosis is observed. So far, however, there are only few patients, maybe due to the selection of the patients and actively utilizing prophylaxis.
Similar articles
-
[Two cases of respiratory infection complicating treatment with infliximab].Nihon Kokyuki Gakkai Zasshi. 2007 Apr;45(4):366-71. Nihon Kokyuki Gakkai Zasshi. 2007. PMID: 17491318 Japanese.
-
Pulmonary infectious complications associated with anti-TNFalpha therapy (infliximab) for rheumatoid arthritis.Intern Med. 2006;45(10):685-8. doi: 10.2169/internalmedicine.45.1623. Epub 2006 Jun 15. Intern Med. 2006. PMID: 16778341
-
Pneumocystis carinii pneumonia following a second infusion of infliximab.Rheumatology (Oxford). 2002 Aug;41(8):951-2. doi: 10.1093/rheumatology/41.8.951. Rheumatology (Oxford). 2002. PMID: 12154220 No abstract available.
-
Tuberculosis and opportunistic infections: relevance to biologic agents.Clin Exp Rheumatol. 2004 Sep-Oct;22(5 Suppl 35):S126-33. Clin Exp Rheumatol. 2004. PMID: 15552526 Review.
-
[Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: II. Clinical conditions special attention needed to be paid to; 3. Opportunistic infections].Nihon Naika Gakkai Zasshi. 2013 Oct 10;102(10):2631-8. doi: 10.2169/naika.102.2631. Nihon Naika Gakkai Zasshi. 2013. PMID: 24400544 Review. Japanese. No abstract available.
Cited by
-
Rheumatoid arthritis increases the risk of nontuberculosis mycobacterial disease and active pulmonary tuberculosis.PLoS One. 2014 Oct 22;9(10):e110922. doi: 10.1371/journal.pone.0110922. eCollection 2014. PLoS One. 2014. PMID: 25337995 Free PMC article.